Market Overview:
The global synthetic peptide vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer, technological advancements in peptide synthesis, and rising investments by key players in this market. Based on type, the global synthetic peptide vaccine market can be segmented into solution phase synthesis (SPS) and solid phase peptide synthesis (SPPS). SPS is a more traditional method for synthesizing peptides and is used for small-molecule drugs. SPPS is a more recent technology that offers several advantages over SPS, including higher yields, shorter production times, and lower costs. SPPS is expected to witness higher growth during the forecast period owing to its advantages over SPS. Based on application, the global synthetic peptide vaccine market can be segmented into prostate cancer, breast cancer, gastric cancer, lung cancer pancreatic cancer,, and others. Prostate cancer accounted for the largest share of this market in 2017 owing to its high incidence rate globally. Breast Cancer was second largest application area with highest CAGR due too increase awareness about breast cancers among women population across globe . Pancreatic Cancer are third largest application area with highest CAGR due too lack of effective treatment options available till date .
Product Definition:
A synthetic peptide vaccine is a vaccine created from man-made peptides as opposed to using proteins from natural sources. Synthetic peptide vaccines are important because they can be designed to more specifically target viruses or bacteria.
Solution Phase Synthesis (SPS):
Solution phase synthesis (SPS) is a process in which synthetic peptide is synthesized by the proteolytic degradation of an insoluble protein. The SPS process can be divided into two parts; namely, solution preparation and reaction mixture preparation. In the first part, the amino acid sequence of immunogenic fragment is determined along with its purity and concentration.
Solid Phase Peptide Synthesis (SPPS):
Solid Phase Peptide Synthesis (SPPS) is a process used for the production of high yield and pure peptides. It involves an efficient isolation procedure that helps in purification, identification, and concentration of amino acids or small peptides. SPPS has been widely accepted as a method to produce large quantities of highly pure proteins with minimal contaminants.
Application Insights:
Breast cancer dominated the global market in terms of revenue generation in 2017. This is due to the high prevalence of breast cancer and increasing research initiatives by key players such as Pfizer, sanofi-aventis, Novartis, and others for developing new drugs for this disease. For instance, in March 2018, sanofi-aventis announced to submit a New Drug Application (NDA) for its investigational compound ZK219 for the treatment of hormone receptor-positive metastatic breast carcinoma after failure with other available therapies.
The company also reported that it plans to apply for U.S. FDA approval under accelerated approval program (Pfizer's protocol) if its lead drug candidate proves effective against hormone receptor positive metastatic breast carcinoma during clinical trials which are ongoing since 2016 named APLIM8 study conducted by Pfizer Inc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of peptide vaccine developers and manufacturers, increased funding for cancer research, high prevalence of cancer among the U.S. population, and rising awareness about synthetic vaccines among patients & physicians in North America.
Growth Factors:
- Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases is one of the major growth drivers for the synthetic peptide vaccine market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of symptoms, including fever, diarrhea, vomiting, and rash. The increasing incidence of infectious diseases is a major public health concern as it can lead to serious complications and even death in some cases. According to the World Health Organization (WHO), there were approximately 1 billion cases of malaria worldwide in 2015 and over 438 000 deaths due to malaria. In addition, there were an estimated 214 million cases of dengue fever globally in 2015 with around 4 500 deaths from dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).
- Growing demand for novel vaccines: The growing demand for novel vaccines is another key growth driver for the synthetic peptide vaccine market. Novel vaccines are those that are developed against new or emerging pathogens that have not been targeted by existing licensed vaccines or those that offer improved protection against existing pathogens compared with currently available licensed vaccines. Synthetic peptide-based vaccine candidates offer several advantages over traditional whole-organism based vaccine candidates such as increased stability and purity as well as potential cost savings during manufacturing process when compared with traditional viral vectors used in vaccine production processes . This has led to an increase in investment into research and development activities focused on developing synthetic pept
Scope Of The Report
Report Attributes
Report Details
Report Title
Synthetic Peptide Vaccine Market Research Report
By Type
Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)
By Application
Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Others
By Companies
Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Anergis, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Synthetic Peptide Vaccine Market Report Segments:
The global Synthetic Peptide Vaccine market is segmented on the basis of:
Types
Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Anergis
- Antigen Express
- Apitope Technology
- Artificial Cell Technologies
- Benovus Bio
- Celgene Corporation
- Immatics biotechnologies
- Merck
- ImmunoCellular Therapeutics
- ISA Pharmaceuticals
- Anergis
- Spotlight Innovation
- OncoTherapy Science
- Peptech
- Pharmasyntez
- Sumitomo Dainippon Pharma
- TapImmune
- Targovax
Highlights of The Synthetic Peptide Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution Phase Synthesis (SPS)
- Solid Phase Peptide Synthesis (SPPS)
- By Application:
- Prostate Cancer
- Breast Cancer
- Gastric Cancer
- Lung Cancer
- Pancreatic Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Synthetic Peptide Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A synthetic peptide vaccine is a vaccine made from a series of short, artificial peptides. These vaccines are designed to help the body build immunity against specific diseases by teaching the immune system to recognize and attack specific proteins found in the disease.
Some of the key players operating in the synthetic peptide vaccine market are Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Anergis, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Synthetic Peptide Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Synthetic Peptide Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Synthetic Peptide Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Synthetic Peptide Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Synthetic Peptide Vaccine Market Size & Forecast, 2018-2028
4.5.1 Synthetic Peptide Vaccine Market Size and Y-o-Y Growth
4.5.2 Synthetic Peptide Vaccine Market Absolute $ Opportunity
Chapter 5 Global Synthetic Peptide Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Synthetic Peptide Vaccine Market Size Forecast by Type
5.2.1 Solution Phase Synthesis (SPS)
5.2.2 Solid Phase Peptide Synthesis (SPPS)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Synthetic Peptide Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Synthetic Peptide Vaccine Market Size Forecast by Applications
6.2.1 Prostate Cancer
6.2.2 Breast Cancer
6.2.3 Gastric Cancer
6.2.4 Lung Cancer
6.2.5 Pancreatic Cancer
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Synthetic Peptide Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Synthetic Peptide Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Synthetic Peptide Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Synthetic Peptide Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Synthetic Peptide Vaccine Market Size Forecast by Type
9.6.1 Solution Phase Synthesis (SPS)
9.6.2 Solid Phase Peptide Synthesis (SPPS)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Synthetic Peptide Vaccine Market Size Forecast by Applications
9.10.1 Prostate Cancer
9.10.2 Breast Cancer
9.10.3 Gastric Cancer
9.10.4 Lung Cancer
9.10.5 Pancreatic Cancer
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Synthetic Peptide Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Synthetic Peptide Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Synthetic Peptide Vaccine Market Size Forecast by Type
10.6.1 Solution Phase Synthesis (SPS)
10.6.2 Solid Phase Peptide Synthesis (SPPS)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Synthetic Peptide Vaccine Market Size Forecast by Applications
10.10.1 Prostate Cancer
10.10.2 Breast Cancer
10.10.3 Gastric Cancer
10.10.4 Lung Cancer
10.10.5 Pancreatic Cancer
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Synthetic Peptide Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Synthetic Peptide Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Synthetic Peptide Vaccine Market Size Forecast by Type
11.6.1 Solution Phase Synthesis (SPS)
11.6.2 Solid Phase Peptide Synthesis (SPPS)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Synthetic Peptide Vaccine Market Size Forecast by Applications
11.10.1 Prostate Cancer
11.10.2 Breast Cancer
11.10.3 Gastric Cancer
11.10.4 Lung Cancer
11.10.5 Pancreatic Cancer
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Synthetic Peptide Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Synthetic Peptide Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Synthetic Peptide Vaccine Market Size Forecast by Type
12.6.1 Solution Phase Synthesis (SPS)
12.6.2 Solid Phase Peptide Synthesis (SPPS)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Synthetic Peptide Vaccine Market Size Forecast by Applications
12.10.1 Prostate Cancer
12.10.2 Breast Cancer
12.10.3 Gastric Cancer
12.10.4 Lung Cancer
12.10.5 Pancreatic Cancer
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Synthetic Peptide Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Synthetic Peptide Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Synthetic Peptide Vaccine Market Size Forecast by Type
13.6.1 Solution Phase Synthesis (SPS)
13.6.2 Solid Phase Peptide Synthesis (SPPS)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Synthetic Peptide Vaccine Market Size Forecast by Applications
13.10.1 Prostate Cancer
13.10.2 Breast Cancer
13.10.3 Gastric Cancer
13.10.4 Lung Cancer
13.10.5 Pancreatic Cancer
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Synthetic Peptide Vaccine Market: Competitive Dashboard
14.2 Global Synthetic Peptide Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Anergis
14.3.2 Antigen Express
14.3.3 Apitope Technology
14.3.4 Artificial Cell Technologies
14.3.5 Benovus Bio
14.3.6 Celgene Corporation
14.3.7 Immatics biotechnologies
14.3.8 Merck
14.3.9 ImmunoCellular Therapeutics
14.3.10 ISA Pharmaceuticals
14.3.11 Anergis
14.3.12 Spotlight Innovation
14.3.13 OncoTherapy Science
14.3.14 Peptech
14.3.15 Pharmasyntez
14.3.16 Sumitomo Dainippon Pharma
14.3.17 TapImmune
14.3.18 Targovax
